Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
anti-inflammatory
Biotech
AbbVie links up with VC firm to map anti-inflammatory companies
While AbbVie has been garnering headlines for its cancer and neurological pipelines, the Big Pharma still has an eye on the inflammatory market.
James Waldron
Nov 28, 2022 7:30am
Acelyrin brings total raised in 1 year past past $500M mark
Sep 13, 2022 10:05am
Inflammation space swells as Nuvig exits stealth mode with $47M
May 11, 2022 9:05am
Chasing Novartis and Roche, Ventus banks $140M for clinical work
Feb 9, 2022 8:12am
Super-fit mice reveal anti-inflammatory brain protein
Dec 10, 2021 8:40am
How a century-old TB vaccine may help fight severe COVID-19
Aug 4, 2021 2:00pm